KalVista Pharmaceuticals (KALV) Debt to Equity (2014 - 2016)
KalVista Pharmaceuticals recorded quarterly Debt to Equity of $0.11 in Q1 2016, up 15.53% quarter-over-quarter from $0.09 in Q4 2015, and up 218.06% year-over-year from $0.03 in Q2 2015.
KalVista Pharmaceuticals' Debt to Equity history runs 3 years deep, the most recent figure standing at $0.11 for Q1 2016.
- In Q1 2016, Debt to Equity rose 218.06% year-over-year to $0.11; the TTM figure through Mar 2016 stood at $0.11 (up 218.06% YoY), while the FY2016 annual figure was -$0.0, changed N/A from the prior year.
- Debt to Equity came in at $0.11 for Q1 2016 at KalVista Pharmaceuticals, up from $0.09 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.11 in Q1 2016 to a low of -$0.1 in Q4 2014.
- A 3-year average of $0.03 and a median of $0.08 in 2015 frame the typical range for Debt to Equity.
- Across the five-year window, Debt to Equity surged 193.11% in 2015 and surged 218.06% in 2016, its largest moves.
- KalVista Pharmaceuticals' Debt to Equity stood at -$0.1 in 2014, then jumped by 193.11% to $0.09 in 2015, then grew by 15.53% to $0.11 in 2016.
- According to Business Quant data, Debt to Equity over the past three periods registered $0.11, $0.09, and $0.08 for Q1 2016, Q4 2015, and Q3 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 0.11 |
| Dec 31, 2015 | 0.09 |
| Sep 30, 2015 | 0.08 |
| Jun 30, 2015 | 0.08 |
| Mar 31, 2015 | -0.09 |
| Dec 31, 2014 | -0.10 |